Hiroko Iseoka

717 citations
15 papers · 476 indexed · h-index 12
Topics
Tissue Engineering and Regenerative Medicine (9 papers)Pluripotent Stem Cells Research (7 papers)Cardiac Structural Anomalies and Repair (3 papers)
Partner nations
JapanFrance

In The Last Decade

Hiroko Iseoka

15 papers receiving 471 citations

Peers

Hiroko Iseoka
Comparison fields: 5 of 62
  • Molecular Biology 262
  • Surgery 249
  • Biomedical Engineering 198
  • Biomaterials 114
  • Cellular and Molecular Neuroscience 71
Replace Maki Takeda with:
Maki Takeda Japan
Pablo Hofbauer Austria
Ienglam Lei United States
Akinori Hirano Japan
Robert C. Coyle United States
Olalla Iglesias‐García Spain
Jason Tchao United States
Sherwin Ting Singapore
Priyadharshini Sivakumaran Australia
Elisa Giacomelli United States
Hiroko Iseoka relative to Maki Takeda Japan Maki Takeda's profile →
Citations per field
00.5×1.5×1.8×
Maki Takeda · 1×
Citations per year

Countries citing papers authored by Hiroko Iseoka

Since Specialization
Citations

This map shows the geographic impact of Hiroko Iseoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Iseoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Iseoka more than expected).

Fields of papers citing papers by Hiroko Iseoka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Iseoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Iseoka. The network helps show where Hiroko Iseoka may publish in the future.

Co-authorship network of co-authors of Hiroko Iseoka

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Iseoka. A scholar is included among the top collaborators of Hiroko Iseoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Iseoka. Hiroko Iseoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 9
2 13
3 66
4 15
5 17
6 4
7 23
8 8
9 19
10 37
11 55
12 81
13 96
14 22
15 11

About Hiroko Iseoka

Hiroko Iseoka is a scholar working on Developmental Neuroscience, Biomaterials and Surgery, having authored 15 papers that have together received 476 indexed citations. Recurring topics across this work include Tissue Engineering and Regenerative Medicine (9 papers), Pluripotent Stem Cells Research (7 papers) and Cardiac Structural Anomalies and Repair (3 papers). The work is most often cited by research in Biomaterials (114 citations), Surgery (249 citations) and Biomedical Engineering (198 citations). Hiroko Iseoka has collaborated with scholars based in Japan and France. Frequent co-authors include Yoshiki Sawa, Shigeru Miyagawa, Emiko Ito, Maki Takeda, Akima Harada, Michiya Matsusaki, Mitsuru Akashi, Satsuki Fukushima, Nagako Sougawa and Atsuhiro Saito. Their work appears in journals such as Scientific Reports, Acta Biomaterialia and Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026